Obinutuzumab is effective for the treatment of frequently-relapsing/steroid-dependent minimal change disease in adults

被引：7

作者：

Jin, Li ^{[1
]}

Liu, Xueying ^{[1
]}

Li, Huixian ^{[1
]}

Dang, Xiangyun ^{[1
]}

Wang, Zhigang ^{[1
]}

Niu, Dan ^{[1
]}

Zhang, Xiaotian ^{[2
]}

Sun, Jiping ^{[1
]}

Hao, Dapeng ^{[1
]}

Lu, Wanhong ^{[1
]}

机构：

[1] Xi An Jiao Tong Univ, Affiliated Hosp 1, Sch Med, Dept Nephrol, Xian, Shaanxi, Peoples R China

[2] Xi An Jiao Tong Univ, Hlth Sci Ctr, Dept Human Anat Histol & Embryol, Xian, Shaanxi, Peoples R China

来源：

NEPHROLOGY DIALYSIS TRANSPLANTATION | 2024年 / 39卷 / 08期

关键词：

CHANGE NEPHROTIC SYNDROME; RITUXIMAB;

D O I：

10.1093/ndt/gfae061

中图分类号：

R3 [基础医学]; R4 [临床医学];

学科分类号：

1001 ; 1002 ; 100602 ;

摘要：

10.1093/ndt/gfae061 Video Watch the video of this contribution at https://academic.oup.com/ndt/pages/author_videos gfae061Media1 6353512852112

引用

页码：1364 / 1367

页数：4

共 18 条

[1] KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease Abstracts [J].

不详 .

KIDNEY INTERNATIONAL, 2021, 99 (03) :S26-S87

[2] New and Old Anti-CD20 Monoclonal Antibodies for Nephrotic Syndrome. Where We Are? [J].

Basu, Biswanath ;

Angeletti, Andrea ;

Islam, Bilkish ;

Ghiggeri, Gian Marco .

FRONTIERS IN IMMUNOLOGY, 2022, 13

[3] THE NEPHROTIC SYNDROME AND ITS COMPLICATIONS [J].

CAMERON, JS .

AMERICAN JOURNAL OF KIDNEY DISEASES, 1987, 10 (03) :157-171

[4] Obinutuzumab in Frequently Relapsing and Steroid-Dependent Nephrotic Syndrome in Children [J].

Dossier, Claire ;

Bonneric, Stephanie ;

Baudouin, Veronique ;

Kwon, Theresa ;

Prim, Benjamin ;

Cambier, Alexandra ;

Couderc, Anne ;

Moreau, Christelle ;

Deschenes, Georges ;

Hogan, Julien .

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2023, 18 (12) :1555-1562

[5] A tale of two antibodies: obinutuzumab versus rituximab [J].

Freeman, Ciara L. ;

Sehn, Laurie H. .

BRITISH JOURNAL OF HAEMATOLOGY, 2018, 182 (01) :29-45

[6] Rituximab as Initial Therapy in Adult Patients With Minimal Change Disease [J].

Guan, Nan ;

Zhang, Min ;

Chen, Ruiying ;

Xie, Qionghong ;

Hao, Chuan-Ming .

KIDNEY INTERNATIONAL REPORTS, 2023, 8 (05) :1102-1104

[7] Rituximab for minimal-change nephrotic syndrome in adulthood: predictive factors for response, long-term outcomes and tolerance [J].

Guitard, Joelle ;

Hebral, Anne-Laure ;

Fakhouri, Fadi ;

Joly, Dominique ;

Daugas, Eric ;

Rivalan, Joseph ;

Guigonis, Vincent ;

Ducret, Francis ;

Presne, Claire ;

Pirson, Yves ;

Hourmant, Maryvonne ;

Glachant, Jean-Claude ;

Vendrely, Benoit ;

Moranne, Olivier ;

Faguer, Stanislas ;

Chauveau, Dominique .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 (11) :2084-2091

[8] The Treatment of Minimal Change Disease in Adults [J].

Hogan, Jonathan ;

Radhakrishnan, Jai .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2013, 24 (05) :702-711

[9] Efficacy of Rituximab for Minimal Change Disease and Focal Segmental Glomerulosclerosis with Frequently Relapsing or Steroid-Dependent Nephrotic Syndrome in Adults: A Chinese Multicenter Retrospective Study [J].

Lan, Lan ;

Lin, Yuxin ;

Yu, Binfeng ;

Wang, Yin ;

Pan, Hong ;

Wang, Huijing ;

Lou, Xiaowei ;

Lang, Xiabing ;

Zhang, Qiankun ;

Jin, Lie ;

Yang, Yi ;

Xiao, Liang ;

Chen, Jianghua ;

Han, Fei .

AMERICAN JOURNAL OF NEPHROLOGY, 2024, 55 (01) :25-36

[10] Rituximab is an efficient and safe treatment in adults with steroid-dependent minimal change disease [J].

Munyentwali, Helene ;

Bouachi, Khedidja ;

Audard, Vincent ;

Remy, Philippe ;

Lang, Philippe ;

Mojaat, Rachid ;

Deschenes, Georges ;

Ronco, Pierre M. ;

Plaisier, Emmanuelle M. ;

Dahan, Karine Y. .

KIDNEY INTERNATIONAL, 2013, 83 (03) :511-516

← 1 2 →